Emergence of Macrolide Resistance during Treatment of Pneumococcal Pneumonia
- 21 February 2002
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (8) , 630-631
- https://doi.org/10.1056/nejm200202213460820
Abstract
The emergence of antibiotic resistance during treatment for pneumococcal infection is exceedingly rare.1 To our knowledge, there is no previous report of a genetically characterized, antibiotic-resistant pneumococcal mutant emerging during therapy and serving as the cause of treatment failure.Keywords
This publication has 7 references indexed in Scilit:
- Comparison of Results Generated by Serotyping, Pulsed-Field Restriction Analysis, Ribotyping, and Repetitive-Sequence PCR Used To Characterize Penicillin-Resistant Pneumococci from the United StatesJournal of Clinical Microbiology, 2001
- Mutation in 23S rRNA Responsible for Resistance to 16-Membered Macrolides and Streptogramins in Streptococcus pneumoniaeAntimicrobial Agents and Chemotherapy, 2001
- Two New Mechanisms of Macrolide Resistance in Clinical Strains of Streptococcus pneumoniae from Eastern Europe and North AmericaAntimicrobial Agents and Chemotherapy, 2000
- The Complete Atomic Structure of the Large Ribosomal Subunit at 2.4 Å ResolutionScience, 2000
- Prevalence of Macrolide Resistance Mechanisms in Streptococcus pneumoniae Isolates from a Multicenter Antibiotic Resistance Surveillance Study Conducted in the United States in 1994-1995Clinical Infectious Diseases, 1999
- The crystal structure of ribosomal protein L22 from Thermus thermophilus: insights into the mechanism of erythromycin resistanceStructure, 1998
- PNEUMOCOCCUS RESISTANT TO ERYTHROMYCIN AND LINCOMYCINThe Lancet, 1967